JPRN-UMIN000003861已完成2 期
Efficacy of adoptive cellular therapy with naive rich T cell on recurrence after curative radiofrequency ablation for primary hepatocellular carcinoma (Phase 2 study) - HCC prevention study by naive rich T cell therapy
Kyoto Prefectural University of Medicine, Division of Gastroenterology and Hepatology0 个研究点目标入组 25 人开始时间: 2010年7月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patient who has uncontrollable severe infectional disease. 2. Patient who has allergic disease or autoimmune disease requiring treatment. 3. Patient who is associated with malignant hypertension, severe congestive heart disease, unsatble angina, myocardial infarction within 6 months prio to registration, severe pulmonary fibrosis and active interstitial pneumonia. 4. Patient who cannot undergo enhanced CT scan or MRI due to some reason such as allergy for contrast media or renal dysfunction. 5. Patient who has uncontrollable associated cancer. 6.Patient with severe drug allergy. 7.Patient with severe psychiatric disorder. 8.In pregnancy or lactation. 9. Patient with HIV or HTLV-1 infection. 10.Patient who is inappropriate.
研究者
相似试验
已完成
1 期
Phase 1/2 study of adoptive cell therapy using cultured tumor infiltrating lymphocytes with lympho-depleting non-myeloablative preconditioning for patients with advanced melanomaJPRN-UMIN000030143Keio University School of Medicine14
已完成
1 期
Phase1 study of adoptive cell transfer therapy for advanced cancer patients, using stimulated T cells by CH-296.unresectable digestive cancer, lung cancerJPRN-UMIN000001835Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine9
招募中
1 期
Activated NK cell therapy to negate MRD in AML patientsAcute myeloid leukemia.C92.0Acute myeloblastic leukemiaIRCT20230801058996N3Shahid Beheshti University of Medical Sciences15
已完成
1 期
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerPeritoneal Cavity CancerOvarian CancerNCT00101257Fred Hutchinson Cancer Center18
已完成
不适用
Evaluation of efficacy of treatment with stem cells (SCs) and platelet-rich plasma (PRP) in patients with knee arthrosisKnee Osteoarthritis.Primary gonarthrosis, bilateralIRCT2012080510507N1Immunology Research Center60